ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 179 filers reported holding ARGENX SE in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $669,600 | +26.0% | 1,362 | -0.1% | 0.00% | – |
| Q2 2023 | $531,592 | +6.2% | 1,364 | +1.6% | 0.00% | – |
| Q1 2023 | $500,375 | -95.1% | 1,343 | -95.0% | 0.00% | -100.0% |
| Q4 2022 | $10,210,000 | -22.2% | 26,952 | -27.5% | 0.00% | -40.0% |
| Q3 2022 | $13,121,000 | -70.2% | 37,162 | -68.1% | 0.01% | -66.7% |
| Q2 2022 | $44,096,000 | -54.4% | 116,385 | -62.0% | 0.02% | -48.3% |
| Q1 2022 | $96,645,000 | -23.7% | 306,509 | -15.2% | 0.03% | -17.1% |
| Q4 2021 | $126,583,000 | +14.9% | 361,470 | -0.9% | 0.04% | 0.0% |
| Q3 2021 | $110,195,000 | -0.7% | 364,888 | -1.0% | 0.04% | +2.9% |
| Q2 2021 | $110,947,000 | +8.2% | 368,514 | -1.0% | 0.03% | 0.0% |
| Q1 2021 | $102,517,000 | -19.2% | 372,257 | -13.8% | 0.03% | -24.4% |
| Q4 2020 | $126,937,000 | -10.1% | 431,629 | -19.7% | 0.04% | -21.1% |
| Q3 2020 | $141,166,000 | +41.7% | 537,733 | +21.5% | 0.06% | +32.6% |
| Q2 2020 | $99,656,000 | +78.6% | 442,460 | +4.5% | 0.04% | +48.3% |
| Q1 2020 | $55,792,000 | -32.6% | 423,528 | -17.8% | 0.03% | -14.7% |
| Q4 2019 | $82,744,000 | +77.0% | 515,475 | +25.7% | 0.03% | +61.9% |
| Q3 2019 | $46,741,000 | – | 410,155 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |